Percutaneous laser ablation in the treatment of hepatocellular carcinoma with small tumors: analysis of factors affecting the achievement of tumor necrosis.

PURPOSE To identify the factors that affect the achievement of tumor necrosis with percutaneous laser ablation (PLA) in patients with hepatocellular carcinoma (HCC) and tumor size no larger than 4.0 cm. MATERIALS AND METHODS Ultrasound-guided biopsy results were retrospectively studied in 99 lesions (range, 0.5-4.0 cm; mean, 2.7 cm) from 82 patients (44 men, 38 women; age range, 50-80 years; median, 68 y) who had undergone PLA. RESULTS Complete tumor ablation was obtained in 90 lesions (90.9%). Of the nine cases in which complete tumor necrosis was not achieved, six had tumors located in sites that did not allow the optimal placement of fibers, and five of these had a tumor diameter greater than 3 cm. Early discontinuation of PLA as a result of decompensation of liver cirrhosis was the reason for not achieving a complete tumor ablation in three other cases. There was a clear relationship between the energy delivered and the volume of necrosis achieved (r = 0.56; P < .001) regardless of the initial size of HCC tumors. The number of illuminations required, and consequently the amount of energy delivered, was also affected by tumor location. In fact, lesions adjacent to large vessels (> or = 3 mm) required a greater number of illuminations than the other lesions to achieve complete ablation (2.9 +/- 1.4 vs 2.3 +/- 0.9; P = .043). The eight cases with undifferentiated histology required more illuminations than the cases with other histologic types (3.4 +/- 0.9 vs 2.2 +/- 0.9; P < .001). However, these cases were located in sites that did not allow the optimal placement of fibers, therefore requiring multiple treatments. CONCLUSION PLA is a highly effective treatment in HCC with a tumor size of 4.0 cm or smaller. In this setting, two variables, tumor size and tumor location, affect the achievement of complete tumor ablation and the number of treatments required to obtain tumor necrosis.

[1]  M. Kojiro,et al.  Pathology of Hepatocellular Carcinoma , 2006 .

[2]  Michiie Sakamoto,et al.  Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection , 1996, Cancer.

[3]  S. Thomsen.  PATHOLOGIC ANALYSIS OF PHOTOTHERMAL AND PHOTOMECHANICAL EFFECTS OF LASER–TISSUE INTERACTIONS , 1991, Photochemistry and photobiology.

[4]  B. Carr,et al.  Hepatocellular carcinoma: current management and future trends. , 2004, Gastroenterology.

[5]  G. Manenti,et al.  Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients. , 2001, Radiology.

[6]  Steven L. Jacques,et al.  Laser Tissue Interaction XIII: Photochemical, Photothermal, and Photomechanical , 1999 .

[7]  Gerhard Müller,et al.  Optical properties of native and coagulated human liver tissue and liver metastases in the near infrared range , 1998, Lasers in surgery and medicine.

[8]  E. Patterson,et al.  Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. , 1998, Annals of surgery.

[9]  Interstitial Laser Photocoagulation with Four Cylindrical Diffusing Fibre Tips: Importance of Mutual Fibre Distance , 1999, Lasers in Medical Science.

[10]  C. Bartolozzi,et al.  Combination of interventional therapies in hepatocellular carcinoma. , 2001, Hepato-gastroenterology.

[11]  James Sayre,et al.  Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect. , 2002, AJR. American journal of roentgenology.

[12]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[13]  J. Bruix,et al.  Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma , 2004, Hepatology.

[14]  G. Dodd,et al.  Thermal ablation for hepatocellular carcinoma. , 2004, Gastroenterology.

[15]  Claudio M Pacella,et al.  Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. , 2001, Radiology.

[16]  J. Cardella,et al.  Society of Interventional Radiology clinical practice guidelines. , 2003, Journal of vascular and interventional radiology : JVIR.

[17]  Johan Olsrud,et al.  Feedback interstitial diode laser (805 nm) thermotherapy system: Ex vivo evaluation and mathematical modeling with one and four‐fibers , 1998, Lasers in surgery and medicine.

[18]  K. Tranberg.  Percutaneous ablation of liver tumours. , 2004, Best practice & research. Clinical gastroenterology.

[19]  W R Lees,et al.  Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. , 2000, Radiographics : a review publication of the Radiological Society of North America, Inc.

[20]  Pietro Andreone,et al.  Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. , 2002, Radiology.

[21]  Noriyuki Moriyama,et al.  Pathology of small hepatocellular carcinoma. A proposal for a new gross classification , 1987, Cancer.